Session Details
[26PO2-pm1]Prevention of drug abuse (medicinal products)/Health economics (Medical economics)
Sat. Mar 26, 2022 1:30 PM - 3:10 PM JST
Sat. Mar 26, 2022 4:30 AM - 6:10 AM UTC
Sat. Mar 26, 2022 4:30 AM - 6:10 AM UTC
[Room PO2] Lounge next to Room K Bldg. 2: 2F
【説明時間】13:45～14:55
[26PO2-pm1-01S]Efforts to drug abuse prevention for pupils: learning effects of participatory experiential learning
○Mizuki Uchida1, Aya Torii2,3, Akira Yoshimi2, Toshitaka Nabeshima4,5, Yukihiro Noda1,2,5 (1. Div. Clin. Sci. Neuropsychopharmacol, Grad. Sch. Pharm., Meijo Univ., 2. Div. Clin. Sci. Neuropsychopharmacol, Fac. Pharm., Meijo Univ., 3. Fac. Pharm., Kinjo Gakuin Univ., 4. Adv. Dia. Syst. Res. Lab., Grad. Sch. Health Sci., Fujita Health Univ., 5. J-DO)
[26PO2-pm1-02]Survey Study on the Appropriate Use of OTC Stimulant Laxatives Using ID-POS Data
○Wakana Yoshimi1, Masashi Tomoda1,2, Eisei Hori1, Tadashi Suzuki1 (1. Grad. Sch. Phar. Sci., Nagoya City Univ.,, 2. WELCIA YAKKYOKU CO., LTD.)
[26PO2-pm1-03]Effect of pharmaceutical education and health support system constructed in junior high school and high school with the participation of students and school pharmacists
○Kazuo Ohyanagi1, Kousuke Okamoto1 (1. Faculty of Pharm. Sci., Hokuriku Univ.)
[26PO2-pm1-04]Estimation of end-of-life medical care costs for cancer patients in Japan using the NDB sampling dataset
○Yuki Takumoto1, Masato Koizumi2 (1. National institute of public health, Center for outcome research evaluation for health., 2. Tokyo Medical and Dental University Graduate School, Health Policy and Informatics Section.)
[26PO2-pm1-05]Health-related quality of life assessment using a web application with EQ-5D-5L assessment function in patients taking high-risk medications by community pharmacists
○Hayato Murata1, Takenori Ichimura2, Chiaki Ogawa3, Satoshi Yuge4, Ryouta Tsukioka5, Keisuke Kado6, Tomonobu Yoshimura7, Kenichi Suzuki8, Hisanaga Nomura9, Katsuaki Miyahara1, Hisanori Shimizu10 (1. QOL Co., Ltd., 2. Showa Univ. Sch. Pharm., 3. Tokyo Medical Center, 4. Nihon Chouzai Co., Ltd., 5. AIN PHARMACIEZ INC., 6. KRAFT Inc., 7. SOGOMEDICAL CO., LTD, 8. Hoshi Univ., 9. National Cancer Center Hospital East, 10. The Cancer Institute Hospital Of JFCR)
[26PO2-pm1-06]First questionnaire survey of community pharmacists’ measurement of health-related quality of life –toward realization
○Masanari Tsuji1, Hayato Murata2, Naoko Umemori2, Kenichi Takahashi3, Tomonobu Yoshimura4, Risa Sato5, Ai Hiramatsu5, Koki Hashimoto5, Takenori Ichimura6, Hisanori Shimizu5, Masakazu Yamaguchi5 (1. AIN PHARMACIEZ INC., 2. QOL Co., Ltd., 3. Nihon chouzai Co., Ltd., 4. SOGO MEDICAL Co., Ltd., 5. The Cancer Institute Hospital Of JFCR, 6. Showa University School of Pharmacy )
[26PO2-pm1-07]Second questionnaire survey of community pharmacists' measurement of health-related quality of life –awareness of web application-
○Tomonobu Yoshimura1, Masanari Tsuji2, Risa Sato3, Hayato Murata4, Naoko Umemori4, Kenichi Takahashi5, Ai Hiramatsu3, Koki Hashimoto3, Takenori Ichimura6, Hisanori Simizu3, Masakazu Yamaguchi3 (1. SOGO MEDICAL Co., Ltd., 2. AIN PHARMACIEZ INC., 3. The Cancer Institute Hospital Of JFCR, 4. QOL Co., Ltd., 5. Nihon Chouzai Co., Ltd., 6. Showa University School of Pharmacy)
[26PO2-pm1-08]Third questionnaire survey of community pharmacists’ measurement of health-related quality of life-awareness and future prospects-
○Risa Sato1, Ai Hiramatsu1, Masanari Tsuji2, Tomonobu Yoshimura3, Hayato Murata4, Naoko Umemori4, Kenichi Takahashi5, Koki Hashimoto1, Takenori Ichimura6, Hisanori Shimizu1, Masakazu Yamaguchi1 (1. The Cancer Institute Hospital Of JFCR, 2. AIN PHARMACIEZ INC., 3. SOGO MEDICAL Co.,Ltd., 4. Qol Co.,Ltd., 5. Nihon Chouzai Co.,Ltd., 6. Showa University School of Pharmacy)